Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 212 out of 61,090 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57,419 | 51,736 |
| Total Cites | 2,248 | 2,704 |
| H-index | 21 | 23 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 154 | 173 |
| Number of Single+First+Last Authored Papers | 282 | 282 |
| Total Cites to Single+First+Last Authored Papers | 558 | 670 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,745 | 1,986 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.36 |
| Self-Citation Percentage |
16.86%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 219 out of 57,585 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64,517 | 60,311 |
| Total Cites | 1,887 | 2,360 |
| H-index | 20 | 21 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 121 | 143 |
| Number of Single+First+Last Authored Papers | 258 | 258 |
| Total Cites to Single+First+Last Authored Papers | 486 | 589 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,571 | 1,833 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.29 |
| Self-Citation Percentage |
20.04%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 268 out of 54,095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71,703 | 68,503 |
| Total Cites | 1,729 | 2,112 |
| H-index | 19 | 21 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 106 | 123 |
| Number of Single+First+Last Authored Papers | 229 | 229 |
| Total Cites to Single+First+Last Authored Papers | 454 | 530 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,416 | 1,636 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.29 |
| Self-Citation Percentage |
18.13%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 274 out of 51,411 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73,062 | 60,774 |
| Total Cites | 1,322 | 1,630 |
| H-index | 17 | 19 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 98 | 129 |
| Number of Single+First+Last Authored Papers | 209 | 209 |
| Total Cites to Single+First+Last Authored Papers | 394 | 458 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,129 | 1,311 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.24 |
| Self-Citation Percentage |
18.90%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 486 out of 49,699 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123,865 | 106,504 |
| Total Cites | 1,596 | 1,951 |
| H-index | 17 | 20 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 114 | 146 |
| Number of Single+First+Last Authored Papers | 191 | 191 |
| Total Cites to Single+First+Last Authored Papers | 493 | 562 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,397 | 1,619 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.21 |
| Self-Citation Percentage |
18.20%
|
|
Peris, Ketty
Fondazione Policlinico Universitario Agostino Gemelli IRCCS Università Cattolica del Sacro Cuore,
Italy
2020 Rank: 122,635
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 467 out of 41,196 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122,635 | 119,210 |
| Total Cites | 1,040 | 1,264 |
| H-index | 14 | 15 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 57 | 71 |
| Number of Single+First+Last Authored Papers | 168 | 168 |
| Total Cites to Single+First+Last Authored Papers | 288 | 331 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 887 | 1,017 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.24 |
| Self-Citation Percentage |
17.72%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Italy7,991 scientists, 7th in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.